Jennifer B Nuzzo1, Jonathan E Golub, Patrick Chaulk, Maunank Shah. 1. Jennifer B. Nuzzo and Patrick Chaulk are with the School of Public Health, Johns Hopkins University, Baltimore, MD. Jennifer B. Nuzzo is also with the UPMC Center for Health Security, Baltimore. Jonathan E. Golub, Patrick Chaulk, and Maunank Shah are with the School of Medicine, Johns Hopkins University, Baltimore. Patrick Chaulk is also with the Baltimore City Health Department, Baltimore.
Abstract
OBJECTIVES: We sought to characterize postimmigration tuberculosis (TB) care for Class B immigrants and refugees at the Baltimore City Health Department TB program (BCHD), and to determine the proportion of immigrants with active TB or latent TB infection (LTBI) in this high-risk population. METHODS: We conducted a retrospective chart review of Class B immigrants and refugees who reported to the BCHD for postimmigration TB evaluation from 2010 to 2012. RESULTS: We reviewed the clinical records of 153 Class B immigrants; 4% were diagnosed with active TB and 53% were diagnosed with LTBI. Fifty percent of active TB cases were culture positive, and 67% were asymptomatic; 100% received and completed active TB therapy at the BCHD. Among those diagnosed with LTBI, 87% initiated LTBI therapy and 91% completed treatment. CONCLUSIONS: The high prevalence of active TB and LTBI found among Class B immigrants underscore the importance for postarrival TB screening. The absence of reported symptoms among the majority of active cases identified during this study suggest that reliance on symptom-based screening protocols to prompt sputa testing may be inadequate for identifying active TB among this high-risk group.
OBJECTIVES: We sought to characterize postimmigration tuberculosis (TB) care for Class B immigrants and refugees at the Baltimore City Health Department TB program (BCHD), and to determine the proportion of immigrants with active TB or latent TB infection (LTBI) in this high-risk population. METHODS: We conducted a retrospective chart review of Class B immigrants and refugees who reported to the BCHD for postimmigration TB evaluation from 2010 to 2012. RESULTS: We reviewed the clinical records of 153 Class B immigrants; 4% were diagnosed with active TB and 53% were diagnosed with LTBI. Fifty percent of active TB cases were culture positive, and 67% were asymptomatic; 100% received and completed active TB therapy at the BCHD. Among those diagnosed with LTBI, 87% initiated LTBI therapy and 91% completed treatment. CONCLUSIONS: The high prevalence of active TB and LTBI found among Class B immigrants underscore the importance for postarrival TB screening. The absence of reported symptoms among the majority of active cases identified during this study suggest that reliance on symptom-based screening protocols to prompt sputa testing may be inadequate for identifying active TB among this high-risk group.
Authors: Kristine M Schmit; Richard Brostrom; Angela Largen; Alexandra Pyan; Zanju Wang; Sundari Mase; Sapna Morris Journal: J Immigr Minor Health Date: 2019-12
Authors: Grace A Noppert; Zhenhua Yang; Philippa Clarke; Wen Ye; Peter Davidson; Mark L Wilson Journal: Ann Epidemiol Date: 2017-05-15 Impact factor: 3.797
Authors: F Naufal; L H Chaisson; K O Robsky; P Delgado-Barroso; H S Alvarez-Manzo; C R Miller; A E Shapiro; J E Golub Journal: Int J Tuberc Lung Dis Date: 2022-06-01 Impact factor: 3.427
Authors: La'Marcus T Wingate; Margaret S Coleman; Christopher de la Motte Hurst; Marie Semple; Weigong Zhou; Martin S Cetron; John A Painter Journal: BMC Public Health Date: 2015-12-01 Impact factor: 3.295
Authors: Robert J Blount; Minh-Chi Tran; Charles K Everett; Adithya Cattamanchi; John Z Metcalfe; Denise Connor; Cecily R Miller; Jennifer Grinsdale; Julie Higashi; Payam Nahid Journal: BMC Public Health Date: 2016-08-25 Impact factor: 3.295
Authors: Grace A Noppert; Mark L Wilson; Philippa Clarke; Wen Ye; Peter Davidson; Zhenhua Yang Journal: BMC Public Health Date: 2017-06-02 Impact factor: 3.295
Authors: Grace A Noppert; Zhenhua Yang; Philippa Clarke; Peter Davidson; Wen Ye; Mark L Wilson Journal: Ann Epidemiol Date: 2019-10-17 Impact factor: 3.797